Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bacille calmette-guerin (1 trial)
csf470 (1 trial)
Filgrastim (neupogen) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
Melanoma (Phase 3)
Trials (1 total)
Trial APIs (4 total)